drugset / Trial / NCT01586091

Safety Study of Levocetirizine and Fexofenadine

NCT01586091

Phase 4 Completed 18 enrolled Charite University, Berlin, Germany
RandomizedCrossoverDouble-blindTreatment

Summary

This Study is to comparison of Efficacy and Consistency of Action of Levocetirizine 5 mg once daily with Fexofenadine 60 mg twice daily in the histamine induced wheal, flare and itch Response.

Timeline

Start
2011-02
Primary completion
2011-11
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fexofenadine Unknown 60 mg Oral
Comparator Levocetirizine Unknown 5 mg Oral